Solène Vigoureux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Solène Vigoureux has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- C. Parquet
Maternité Notre-Dame-de-Bon-Secours, Groupe Hospitalier Paris-Saint- Joseph, 185, rue Raymond-Losserand, 75876 Paris cedex 14, France
1 shared publication C. Werschuren
Maternité Notre-Dame-de-Bon-Secours, Groupe Hospitalier Paris-Saint- Joseph, 185, rue Raymond-Losserand, 75876 Paris cedex 14, France
1 shared publication- Catherine Crenn-Hebert
Perinat-ARS-IDF, Regional Health Agency of Ile-de-France (ARS-IDF), 93200 Saint-Denis, France
1 shared publication - Catherine Deneux-Tharaux
Université Paris Cité, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, CRESS U1153, INSERM, INRAE, Paris, France
1 shared publication - Charlotte Ngô
Gynecological and Breast Surgery and Cancerology Center, RAMSAY-Générale de Santé, Hôpital Privé des Peupliers, 75013 Paris, France
1 shared publication - E. Haab
Maternité Notre-Dame-de-Bon-Secours, Groupe Hospitalier Paris-Saint- Joseph, 185, rue Raymond-Losserand, 75876 Paris cedex 14, France
1 shared publication
Latest Publications
- 9 July 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (10) , 666-674
Dépistage et parcours de soins en cas de vulnérabilités psycho-sociales maternelles : une enquête nationale française
- 9 July 2022
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 50 (10) , 666-674
Dépistage et parcours de soins en cas de vulnérabilités psycho-sociales maternelles : une enquête nationale française
- Open Access
- 5 April 2019
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 317
Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study
In France, a Pap test for cervical cancer screening is recommended every three years for all sexually active women aged 25 to 65 years. Modes of contraception (any or no contraception, with or without a visit to a physician, and with or without a gynecological examination) may influence adhesion to screening: women who use intrauterine device (IUD) should be more up to date with their cervical cancer screening more often than those using other means of contraception. Our objectives were to analyze the association between modes of contraception and Pap tests for screening. This cross sectional study is based on the CONSTANCES cohort enabled us to include 16,764 women aged 25–50 years. The factors associated with adhesion to cervical cancer screening (defined by a report of a Pap test within the previous 3 years) was modeled by logistic regression. Missing data were imputed by using multiple imputations. The multivariate analyses were adjusted for sex life, social and demographic characteristics, and health status. Overall, 11.2% (1875) of the women reported that they were overdue for Pap test screening. In the multivariate analysis there was no significant difference between women using an IUD and those pills or implant of pap test overdue ORa:0.9 CI95% [0.8–1.1], ORa 1.3 CI95% [0.7–2.7] respectively. Women not using contraceptives and those using non-medical contraceptives (condoms, spermicides, etc.) were overdue more often ORa: 2.6 CI95% [2.2–3.0] and ORa: 1.8 CI95% [1.6–2.1] respectively than those using an IUD. Women seeing medical professionals for contraception are more likely to have Pap tests.
- 5 April 2019
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 317
Open AccessPap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study
In France, a Pap test for cervical cancer screening is recommended every three years for all sexually active women aged 25 to 65 years. Modes of contraception (any or no contraception, with or without a visit to a physician, and with or without a gynecological examination) may influence adhesion to screening: women who use intrauterine device (IUD) should be more up to date with their cervical cancer screening more often than those using other means of contraception. Our objectives were to analyze the association between modes of contraception and Pap tests for screening. This cross sectional study is based on the CONSTANCES cohort enabled us to include 16,764 women aged 25–50 years. The factors associated with adhesion to cervical cancer screening (defined by a report of a Pap test within the previous 3 years) was modeled by logistic regression. Missing data were imputed by using multiple imputations. The multivariate analyses were adjusted for sex life, social and demographic characteristics, and health status. Overall, 11.2% (1875) of the women reported that they were overdue for Pap test screening. In the multivariate analysis there was no significant difference between women using an IUD and those pills or implant of pap test overdue ORa:0.9 CI95% [0.8–1.1], ORa 1.3 CI95% [0.7–2.7] respectively. Women not using contraceptives and those using non-medical contraceptives (condoms, spermicides, etc.) were overdue more often ORa: 2.6 CI95% [2.2–3.0] and ORa: 1.8 CI95% [1.6–2.1] respectively than those using an IUD. Women seeing medical professionals for contraception are more likely to have Pap tests.
- 1 September 2014
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 42 (9) , 626-627
1re journée de formation sur sexualité et adolescence pour les internes en gynécologie
- 1 September 2014
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 42 (9) , 626-627
1re journée de formation sur sexualité et adolescence pour les internes en gynécologie